Two sampling time profiles for the abbreviated estimation of mycophenolic acid area under the curve in adult renal transplant recipients treated with mycophenolate mofetil and concomitant tacrolimus

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 5, 2009, Pages 531-537

  Tutor Crespo, M J ^a   Hermida, J ^a   Romero, R ^a   Tutor, J C ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Area under the time concentration curve; Limited sampling strategy; Mycophenolic acid; Renal transplantation; Two sampling time profiles

Indexed keywords

MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLASSIFICATION ALGORITHM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE;

ADULT; AGED; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TACROLIMUS;

EID: 70049114746     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01034.x     Document Type: Article

References (21)

1. Bullingham RE, Nicholls Aj, Kamm BR (1998) Clinical Pharmacokinetics of mycophenolate mofetil. Clinical Pharmacokinetics, 34, 429 455.
2. van Gelder T, Le Meur Y, Shaw LM et al. (2006) Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Therapeutic Drug Monitoring, 28, 145 154.
3. van Gelder T, Shaw LM (2005) The rationale for and limitations of therapeutic drug monitoring of mycophenolate mofetil in transplantation. Transplantation, 80, S244 S253.
4. Holt DW (2002) Monitoring mycophenolic acid. Annals of Clinical Biochemistry, 39, 173 183.
5. Arns W, Cibrik DM, Walker RG et al. (2006) Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature. Transplantation, 82, 1004 1012.
6. Ng J, Rogosheske J, Barker J, Weisdorf D, Jacobson PA (2006) A limited sampling model for estimation of total and unbound mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplantation (HCT). Therapeutic Drug Monitoring, 28, 394 401.
7. Weber LT, Hoecker B, Armstrong VW, Oellerich M, Tönshoff B (2006) Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients. Therapeutic Drug Monitoring, 28, 623 631.
8. Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM (2002) Limited sampling strategy for the estimation of mycophenolic acid under the curve in adult transplant patients treated with concomitant tacrolimus. Clinical Chemistry, 48, 1497 1504.
9. Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrzak J, Gralak B (2006) Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. Journal of Clinical Pharmacy and Therapeutics, 31, 27 34.
10. Shaw LM, Pawinski T, Korecka M, Nawrocki A (2002) Monitoring of mycophenolic acid in clinical transplantation. Therapeutic Drug Monitoring, 24, 68 73.
11. Hale M, Nicholls AJ, Bullingham RES et al. (1998) The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clinical Pharmacology and Therapeutics, 64, 672 683.
12. van Hest RM, van Gelder T, Vultyo AG, Mathot RAA (2005) Population pharmacokinetics of mycophenolic acid in renal transplant recipients. Clinical Pharmacokinetics, 44, 1083 1096.
13. David-Neto E, Pereira LM, Kakehashi E et al. (2005) The need of mycophenolic acid monitoring in long-term renal transplants. Clinical Transplantation, 19, 19 25.
14. Shah VP, Midha KK, Dighe S et al. (1991) Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. European Journal of Drug Metabolism and Pharmacokinetics, 16, 249 255.
15. Borrows R, Chusney G, Loucaidou M et al. (2006) Mycophenolic acid 12-h through levels in renal transplantation: association with acute rejection and toxicity. American Journal of Transplantation, 6, 121 128.
16. Weber LT, Shipkova M, Armstrong VW et al. (2002) Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate therapy. Clinical Chemistry, 48, 517 523.
17. Shaw LM, Nicholls A, Hale M et al. (1998) Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clinical Biochemistry, 31, 317 322.
18. Zicheng Y, Peijun Z, Da X, Xianghui W, Hongzhuan C (2006) Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal patients. British Journal of Clinical Pharmacology, 62, 446 452.
19. Op den Buijsch RAM, van de Plas A, Bekers O et al. (2007) Evaluation limited sampling strategies for tacrolimus (abstract). Therapeutic Drug Monitoring, 29, 474.
20. Gornall AG (1986) Basic concepts in laboratory investigation. In : Gornall AG, ed. "Applied biochemistry of clinical disorders'', 2nd edn. Philadelphia : JB Lippincott Company, 3 13.
21. Cattaneo D, Baldelli S, Cortinovis M et al. (2007) Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients (abstract). Therapeutic Drug Monitoring, 29, 472.